LeMaitre Vascular, Inc. (LMAT) Q4 2012 Earnings Results

Lemaitre Vascular Misses on EPS, Stock Up 1.16%

The earnings report indicates that Lemaitre Vascular did not meet EPS expectations, which could raise concerns among investors. However, the stock rose by 1.16%, suggesting that the market may be reacting positively to management's long-term growth strategies despite the EPS miss. Investors will be watching closely for future performance and any updates on product development.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.04	N/A	-27.27%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management remains focused on innovation and expanding market presence. They acknowledged the current earnings miss but emphasized their commitment to future growth.

Management highlighted ongoing investments in product development.

They expressed confidence in long-term growth despite short-term challenges.

Lemaitre Vascular Misses on EPS, Stock Up 1.16%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Misses on EPS, Stock Up 1.16%

Key numbers

Management commentary